{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:36:29Z","timestamp":1791995789646,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2720,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/modpathol.2015.65","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T07:44:39Z","timestamp":1432885479000},"page":"1043-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":278,"title":["BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations"],"prefix":"10.1016","volume":"28","author":[{"given":"Marta","family":"Cigognetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fisogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Balzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Bercich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Bugatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Murer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Barbareschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vermi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.65_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/aje\/kwh025","article-title":"Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003","volume":"159","author":"Price","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1038\/modpathol.2015.65_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Yang","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1038\/modpathol.2015.65_bib3","unstructured":"Surveillance, Epidemiology, and End Results Program. In: NCI (http:\/\/seer.cancer.gov\/) 2015."},{"key":"10.1038\/modpathol.2015.65_bib4","series-title":"Registro Nazionale dei Mesoteliomi. Quarto Rapporto","author":"Marinaccio","year":"2012"},{"key":"10.1038\/modpathol.2015.65_bib5","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.26229","article-title":"Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register","volume":"130","author":"Marinaccio","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2015.65_bib6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2015.65_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.20820","article-title":"Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models","volume":"115","author":"Marinaccio","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2015.65_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/hupa.2002.128248","article-title":"Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers","volume":"33","author":"Ordonez","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.65_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ordonez","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.65_bib10","series-title":"Tumors of the Serosal Membranes","first-page":"83","article-title":"Separation of benign and malignant mesothelial proliferations","author":"Churg","year":"2006"},{"key":"10.1038\/modpathol.2015.65_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"136","author":"Churg","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.65_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.65_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F","article-title":"The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis","volume":"189","author":"Cury","year":"1999","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.65_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1309\/XL6K-8E62-9FLD-V8Q8","article-title":"Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies","volume":"116","author":"Roberts","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.65_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","article-title":"The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.65_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/AJCP5KNL7QTELLYI","article-title":"Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells","volume":"141","author":"Minato","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.65_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.1711680406","article-title":"Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium","volume":"168","author":"Ramael","year":"1992","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.65_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.1711680407","article-title":"p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections","volume":"168","author":"Mayall","year":"1992","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.65_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0046-8177(94)90115-5","article-title":"p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens","volume":"25","author":"Cagle","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.65_bib20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/PAS.0b013e318218985b","article-title":"Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation","volume":"35","author":"Shi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.65_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0b013e31826ab1c0","article-title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations","volume":"37","author":"Lee","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.65_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/modpathol.3800732","article-title":"Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma","volume":"20","author":"Kato","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.65_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","article-title":"The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations","volume":"135","author":"Monaco","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.65_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.5858\/arpa.2011-0219-OA","article-title":"Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions","volume":"136","author":"Lagana","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.65_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00428-012-1344-6","article-title":"Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma","volume":"462","author":"Mogi","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2015.65_bib26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lungcan.2013.12.009","article-title":"How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study","volume":"83","author":"Husain","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1038\/modpathol.2015.65_bib27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/dc.22821","article-title":"CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma","volume":"40","author":"Pinheiro","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2015.65_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2303.2000.00211.x","article-title":"Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis","volume":"11","author":"Dejmek","year":"2000","journal-title":"Cytopathology"},{"key":"10.1038\/modpathol.2015.65_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/dc.20486","article-title":"The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant","volume":"34","author":"Aerts","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2015.65_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPWFW7O1FVFLKT","article-title":"Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids","volume":"131","author":"Shen","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.65_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncy.20071","article-title":"The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions","volume":"118","author":"Hasteh","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/modpathol.2015.65_bib32","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","article-title":"Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium","volume":"23","author":"Sato","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.65_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.humpath.2009.04.030","article-title":"IMP3\/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3\/L523S in effusion cytology","volume":"41","author":"Ikeda","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.65_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/dc.21398","article-title":"Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations","volume":"39","author":"Ikeda","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2015.65_bib35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/dc.21489","article-title":"Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry","volume":"39","author":"Su","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2015.65_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2303.1997.42575425.x","article-title":"p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology","volume":"8","author":"Mayall","year":"1997","journal-title":"Cytopathology"},{"key":"10.1038\/modpathol.2015.65_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.65_bib38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1440-1827.2010.02534.x","article-title":"9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis","volume":"60","author":"Takeda","year":"2010","journal-title":"Pathol Int"},{"key":"10.1038\/modpathol.2015.65_bib39","doi-asserted-by":"crossref","unstructured":"Sheffield BS, Hwang HC, Lee AF et al. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol; advance online publication, 28 January 2015 (e-pub ahead of print).","DOI":"10.1097\/PAS.0000000000000394"},{"key":"10.1038\/modpathol.2015.65_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"10.1038\/modpathol.2015.65_bib41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2015.65_bib42","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2015.65_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity","volume":"69","author":"Nishikawa","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2015.65_bib44","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1038\/sj.onc.1202243","article-title":"A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability","volume":"17","author":"Shen","year":"1998","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2015.65_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2015.65_bib46","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","article-title":"Germline mutations in BAP1 impair its function in DNA double-strand break repair","volume":"74","author":"Ismail","year":"2014","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2015.65_bib47","doi-asserted-by":"crossref","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","article-title":"The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1","volume":"284","author":"Machida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2015.65_bib48","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/MCB.00396-10","article-title":"The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression","volume":"30","author":"Yu","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1038\/modpathol.2015.65_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2015.65_bib50","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1038\/modpathol.2015.65_bib51","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.28521","article-title":"Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma","volume":"120","author":"Joseph","year":"2014","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.65_bib52","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2015.65_bib53","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.65_bib54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2015.65_bib55","first-page":"1365","article-title":"Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells","volume":"39","author":"Yoshikawa","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1038\/modpathol.2015.65_bib56","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1038\/modpathol.2015.65_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12253-013-9677-2","article-title":"BAP1 protein is a progression factor in malignant pleural mesothelioma","volume":"20","author":"Arzt","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"10.1038\/modpathol.2015.65_bib58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2015.65_bib59","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2015.65_bib60","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.imbio.2009.06.013","article-title":"Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage","volume":"214","author":"Vermi","year":"2009","journal-title":"Immunobiology"},{"key":"10.1038\/modpathol.2015.65_bib61","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jclinpath-2013-201609","article-title":"Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.65_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2559.2005.02331.x","article-title":"Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data","volume":"48","author":"King","year":"2006","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.65_bib63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAS.0000000000000176","article-title":"p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma","volume":"38","author":"Hwang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.65_bib64","series-title":"Tumors of the Serosal Membranes","first-page":"11","article-title":"Cytology of the serosal surfaces","author":"Churg","year":"2006"},{"key":"10.1038\/modpathol.2015.65_bib65","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.65_bib66","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2015.65_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2559.2000.00981.x","article-title":"Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms","volume":"37","author":"Attanoos","year":"2000","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.65_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2559.2003.01583.x","article-title":"Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study","volume":"42","author":"Lucas","year":"2003","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.65_bib69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2559.2009.03298.x","article-title":"Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"54","author":"Takeshima","year":"2009","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.65_bib70","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.5858\/2010-0086-RAR.1","article-title":"Sarcomatoid neoplasms of the lung and pleura","volume":"134","author":"Travis","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.65_bib71","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/modpathol.2009.180","article-title":"Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases","volume":"23","author":"Klebe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.65_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/path.1810","article-title":"Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling","volume":"207","author":"Sun","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.65_bib73","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. IV edn","first-page":"165","article-title":"Sarcomatoid, desmoplastic, and biphasic mesothelioma","author":"Roggli","year":"2015"},{"key":"10.1038\/modpathol.2015.65_bib74","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","article-title":"Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition","volume":"20","author":"de Reynies","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2015.65_bib75","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2015.65_bib76","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/annonc\/mdr477","article-title":"Importance of gender in diffuse malignant peritoneal mesothelioma","volume":"23","author":"Cao","year":"2012","journal-title":"Ann Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201565","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:58Z","timestamp":1760230138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222013874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0893395222013874"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.65","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.65","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}